Literature DB >> 14677036

Acute myocarditis associated with adenoviral infection in a patient with scleroderma.

Magdalena Dziadzio1, Andrea Giovagnoni, Giovanni Pomponio, Andrea Recanatini, Osmy Paci della Costanza, Aldo Manzin, Walter Casagrande, Armando Gabrielli.   

Abstract

We describe a 40-year-old man with limited scleroderma who presented with acute heart failure following a flu-like illness. He was known to have incomplete left anterior bundle branch block, initial isolated pulmonary hypertension with enlarged right atrium, and no pulmonary fibrosis. He received therapy for acute heart failure and was transferred to a scleroderma centre for specific treatment of scleroderma cardiomyopathy. Investigations showed raised inflammatory markers and diffuse hyperechogenic thickening of the myocardium on echocardiography. Contrast-enhanced (Gd-DOTA) cardiovascular magnetic resonance imaging (CV-MRI) showed multiple areas of non-homogeneous delayed hyperenhancement in the left ventricle, suggestive of myocarditis. Antiadenovirus IgM antibodies were detected with a titer consistent with recent infection. Six weeks later a repeat Gd-DOTA CV-MRI showed an almost complete resolution of the areas of hyperenhancement and there was a significant reduction in the adenovirus antibody titer with serological conversion to IgG. To our knowledge this is the first report of viral myocarditis in scleroderma. Infections are important causes of morbidity and mortality in this disease and should always be included in the differential diagnosis of cardiac symptoms. We propose that contrast-enhanced CV-MRI is valuable in a non-invasive diagnosis of heart disease in patients with scleroderma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14677036     DOI: 10.1007/s10067-003-0794-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

Review 1.  Myocarditis.

Authors:  A M Feldman; D McNamara
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

Review 2.  Magnetic resonance imaging evaluation of myocardial and pericardial disease.

Authors:  H Frank; S Globits
Journal:  J Magn Reson Imaging       Date:  1999-11       Impact factor: 4.813

3.  Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association.

Authors:  W P Follansbee; T R Zerbe; T A Medsger
Journal:  Am Heart J       Date:  1993-01       Impact factor: 4.749

Review 4.  The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology.

Authors:  J G Coghlan; D Mukerjee
Journal:  Curr Opin Rheumatol       Date:  2001-11       Impact factor: 5.006

5.  Effect of systemic sclerosis on left ventricular long-axis motion and left ventricular mass assessed by magnetic resonance.

Authors:  S P Karwatowski; N A Chronos; H Sinclaire; S M Forbat; M G St John Sutton; C Black; S R Underwood; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2000       Impact factor: 5.364

6.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

7.  Acute myocarditis in fulminant systemic sclerosis.

Authors:  B S Clemson; W R Miller; J C Luck; J A Feriss
Journal:  Chest       Date:  1992-03       Impact factor: 9.410

Review 8.  Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy.

Authors:  M J Sole; P Liu
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

9.  Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.

Authors:  M Oudkerk; P E Sijens; E J Van Beek; T J Kuijpers
Journal:  Invest Radiol       Date:  1995-02       Impact factor: 6.016

10.  Association of myositis and myocarditis in progressive systemic sclerosis.

Authors:  S G West; P J Killian; O J Lawless
Journal:  Arthritis Rheum       Date:  1981-05
View more
  3 in total

1.  Delayed contrast enhancement in a patient with perimyocarditis on contrast-enhanced cardiac MRI: case report.

Authors:  Kunihiko Teraoka; Masaharu Hirano; Minoru Yannbe; Yuka Ohtaki; Toyoyuki Ohkubo; Kimihiko Abe; Akira Yamashina
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

2.  Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance.

Authors:  Nicolò Schicchi; Gianluca Valeri; Gianluca Moroncini; Giacomo Agliata; Luca Salvolini; Armando Gabrielli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2014-06-07       Impact factor: 3.469

Review 3.  Non-invasive imaging in the diagnosis of acute viral myocarditis.

Authors:  Michael Jeserich; Stavros Konstantinides; Gabor Pavlik; Christoph Bode; Annette Geibel
Journal:  Clin Res Cardiol       Date:  2009-09-11       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.